Surprisingly, we demonstrated that RIME KO decreased the proportion of pro‐tumour M2 macrophages in ESCC xenografts while increasing CD4+ T cells and anti‐tumour M1 macrophages proportion in ESCC xenografts. Here, CD4 is linked to esophageal squamous cell carcinoma.